Adlai Nortye ANL
NASDAQ ANL
$15.09 -0.67 (-4.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Invested Capital (2022 - 2026)

Updated

Adlai Nortye (ANL) posted Invested Capital of $239.79 million for Q2 2026, up 361.4% from $51.97 million a year earlier.

Analysis

Adlai Nortye (ANL) Invested Capital (2022 - 2026) Analysis & Trends

For FY2025, Adlai Nortye's Invested Capital came in at $16.26 million, down 68.6% from FY2024.

  • Annual Invested Capital shows a three-year compound annual growth rate of -32.7% (FY2022 to FY2025).
  • In prior years, Adlai Nortye's Invested Capital was $51.82 million in FY2024 (-50.8%), $105.4 million in FY2023 (+97.5%) and $53.38 million in FY2022.
  • On a year-over-year basis, Invested Capital increased in 1 of the last four quarters, with growth averaging 54.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Adlai Nortye 541.15 Mn 441.85 Mn - 239.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239.79 Mn
Dec 31, 2025 16.26 Mn
Jun 30, 2025 51.97 Mn
Dec 31, 2024 51.82 Mn
Jun 30, 2024 92.26 Mn
Dec 31, 2023 74.44 Mn
Dec 31, 2022 48.78 Mn
API Access

Adlai Nortye Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ANL&period=max&api_key=YOUR_API_KEY